Your browser doesn't support javascript.
loading
Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma.
Chen, Inna; Raymond, Victoria M; Geis, Jennifer A; Collisson, Eric A; Jensen, Benny V; Hermann, Kirstine L; Erlander, Mark G; Tempero, Margaret; Johansen, Julia S.
Afiliação
  • Chen I; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
  • Raymond VM; Trovagene, Inc., San Diego, California, USA.
  • Geis JA; Trovagene, Inc., San Diego, California, USA.
  • Collisson EA; Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Jensen BV; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
  • Hermann KL; Department of Radiology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
  • Erlander MG; Trovagene, Inc., San Diego, California, USA.
  • Tempero M; Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Johansen JS; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
Oncotarget ; 8(58): 97769-97786, 2017 Nov 17.
Article em En | MEDLINE | ID: mdl-29228650
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Dinamarca